Sperex

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sperex

Quick Facts: Sperex (Cefaclor)

Property Description
Active ingredient Cefaclor
Form Oral (capsules, tablets, suspension)
Pharmacological class Second-generation cephalosporin
Common use Systemic antibacterial agent
Origin Semi-synthetic derivative

What Type of Antibiotic is Sperex (Cefaclor)?

Sperex is a prescription-only brand name for a semi-synthetic antibiotic whose medicinal activity comes from the compound Cefaclor. Cefaclor is systematically categorized as a second-generation cephalosporin, which is a fundamental type of beta-lactam antibiotic. This classification indicates that the drug is designed to be effective against a broad spectrum of both Gram-positive and specific Gram-negative bacteria.

The active compound is a semi-synthetic derivative originating from the Cephalosporin C nucleus, developed to offer specific stability and an expanded range of bacterial targets compared to its predecessors. It is intended for oral administration and is commercially available in multiple pharmaceutical preparations, including capsules, tablets, and granules for oral suspension. The granule form is often manufactured with features to make administration easier for pediatric patients requiring an orally administered suspension.


What is the General Purpose of Taking Cefaclor?

The general purpose of taking Cefaclor is to resolve systemic bacterial infections by eliminating the disease-causing pathogens. The core mechanism of Cefaclor is bactericidal, meaning it actively kills susceptible bacterial cells rather than simply inhibiting their reproduction. Cefaclor's potent bactericidal activity makes it a tool in combating infection. It achieves this by disrupting the formation and maintenance of the bacterial cell wall, a critical outer structure for the survival of the organism, thereby controlling the infection and aiding the body's recovery process.

Regulatory References

  1. Cefaclor (MedlinePlus Drug Information)
  2. Cefaclor Drug Label (DailyMed)
  3. Cefaclor Mechanism of Action (MedlinePlus)

What side effects are possible with Sperex?

Possible Side Effects and Safety Information

The safety profile of Sperex (Cefaclor) is documented according to regulatory classifications that group adverse reactions by frequency and affected body system. The classification of effects, ranging from common to rare, defines the officially recognized risks associated with the medicine.

Adverse Reaction Scope and Frequency

Adverse reactions are primarily grouped into system-organ classes, with effects noted across the gastrointestinal, dermatological, nervous system, and hematological (blood) systems. Regulatory documents classify the following effects as common (occurring in 1% or more of patients): diarrhea, nausea, headache, rash, and vaginitis.

Less frequently reported, or rare, adverse reactions include vomiting, transient hepatitis, cholestatic jaundice, and interstitial nephritis. These frequency classifications establish the general likelihood of experiencing a particular reaction during treatment.

Serious Adverse Reactions and Safety Constraints

Official labeling identifies several severe adverse reactions, which, while rare, are critical safety considerations. These include anaphylaxis and severe cutaneous adverse reactions such as Stevens-Johnson syndrome. Furthermore, Pseudomembranous colitis is documented as a serious risk that can emerge during or even after the completion of antibiotic therapy. The risk of seizures is also noted, particularly in the context of impaired renal function.

As a cephalosporin, Sperex carries the potential for cross-sensitivity with penicillins, which is a primary safety constraint. Pediatric patients have been reported to have a higher incidence of serum-sickness-like reactions. Prolonged use carries the risk of superinfection due to the overgrowth of non-susceptible organisms. Additionally, the medicine may cause a false-positive reaction for glucose in the urine when tested with non-specific methods, a safety element relevant to laboratory testing.

Overdose and Emergency Response

An overdose of Sperex (Cefaclor) is documented in official regulatory labeling as presenting with primary gastrointestinal manifestations. These include nausea, vomiting, epigastric distress, and diarrhea, with the severity of these effects noted to be dose-related.

Immediate medical attention must be sought for any suspected overexposure. The most serious outcome noted in the context of Cefaclor overdosage is the potential for seizures, a recognized complication of the cephalosporin class, particularly in patients who have pre-existing renal impairment where the drug elimination is slowed.

Management is strictly symptomatic and supportive therapy, as no specific antidote is currently documented in prescribing information. Regulatory guidance emphasizes that careful clinical observation and laboratory studies are required during the management period. The necessity for gastrointestinal decontamination is restricted; it is generally not required unless the estimated ingested dose is five times the total normal daily dose or greater. Procedures like hemodialysis are not established as beneficial for routine overdose management.

Therapeutic Uses of Sperex

Sperex is generally considered relevant in contexts marked by increased discomfort or tension, and may be applied across domains where additional symptomatic support is appropriate. This medication is commonly used to help with symptoms that interfere with daily functioning and is considered relevant in clinical settings that involve acute or unstable symptom patterns.

Acute symptomatic episodes often require focused, short-term treatment. Sperex is commonly used in situations involving certain distressing symptoms and may assist in easing the overall symptom burden during challenging periods.

The therapeutic use of Sperex is generally relevant for managing symptoms associated with recurrent manifestations, episodic discomfort, and heightened physiological stress. It is relevant for easing symptom clusters that may become intense or disruptive, particularly in conditions characterized by periods of increased discomfort. Sperex may assist with maintaining functional stability and offers symptomatic relief that may help patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Acute Discomfort

Sperex may be applied when short-term symptom stabilization is important during phases where the patient experiences heightened discomfort or functional strain.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Sperex (Cefaclor)


Category Official Regulatory Statement
Populations for whom use is contraindicated Patients with a documented hypersensitivity to Cefaclor or to any antibiotic belonging to the cephalosporin group.
Age-related eligibility rules Infants less than one month old: Safety and efficacy have not been established. Children under 16 years: Safety/efficacy of extended-release tablets is not established.
Condition-specific eligibility rules Patients with markedly impaired renal function require administration with caution and observation. Use with caution is also advised for those with a history of gastrointestinal disease, particularly colitis.
Pregnancy and lactation eligibility status Pregnancy: Use not recommended/must be avoided unless considered essential. Lactation: Use with caution as small amounts are detected in breast milk.
Eligibility-related restrictions Extreme caution is required if the patient has a history of a severe penicillin allergy due to the documented risk of cross-hypersensitivity among beta-lactam drugs.

Connection to the Overall Eligibility Profile

Regulatory documents define who can and cannot use Sperex by strictly prohibiting its use in cases of cephalosporin allergy. All other restrictions are based on conditional use rules, mandating caution for patients with impaired renal function and colitis history, and establishing explicit age limitations for pediatric use where efficacy and safety data are officially not established.

What should I know about interactions with other medicines?

Sperex Interactions with other medicines and products

Interaction Scope

The regulatory profile of Sperex (Cefaclor) documents interactions primarily involving agents that alter its clearance, oral anticoagulants, and certain antacids. Specific interacting medicines explicitly noted in regulatory documents include Probenecid and Warfarin. The mechanistic basis of the most significant interactions is the inhibition of renal excretion by Probenecid, which results in increased Cefaclor serum levels. The labels also note diminished absorption caused by certain aluminum or magnesium-containing antacids, and a reduction of peak plasma concentration (Cmax) for the immediate-release formulation when taken with food.


Timing and Restrictions

A formal timing-based interaction rule is specified for co-administration with aluminum or magnesium hydroxide-containing antacids: the extended-release tablets must be separated from these antacids by at least one hour. The pharmacodynamic interaction with oral anticoagulants like Warfarin is based on rare reports of increased prothrombin time with or without clinical bleeding. The absorption reduction effect of antacids applies specifically to the extended-release tablet formulation. No substances are listed as strictly contraindicated based on an interaction mechanism, and there are no population-specific interaction notes officially defined as enhancing interaction severity.


Official Interaction Statements

The overall interaction structure is defined by pharmacokinetic constraints related to elimination and absorption, and a pharmacodynamic caution with anticoagulants. This structure guides necessary administration adjustments to maintain proper systemic drug exposure and manage potential risks.

Mechanism of Action

How Sperex Works

Sperex (Cefaclor) operates through a bactericidal mechanism that directly targets the structural integrity of susceptible bacterial cells, resulting in the lysis and loss of viability of those cells.

️ Irreversible Inhibition of Cell Wall Construction

The drug's primary action involves binding to and irreversibly inhibiting Penicillin-Binding Proteins (PBPs), which are essential transpeptidase enzymes located in the bacterial cell wall. This molecular interference prevents the cross-linking of peptidoglycan units—the final, essential step in constructing the rigid bacterial cell wall. This mechanism directly affects the pathogen's ability to maintain its physical form and structural integrity.

Lysis and Elimination of Pathogenic Cells

By disrupting the bacterial cell wall pathway, the drug triggers a fatal cellular cascade. The resulting defective cell wall cannot withstand the high internal osmotic pressure, causing the bacterial cell to rapidly swell and rupture (lysis). This process is often accelerated by the bacteria's own autolytic enzymes. The destructive mechanism results in the elimination of susceptible bacteria via lysis, defining the drug's fundamental physiological consequence at the cellular level.

Constraints from Bacterial Defense Mechanisms

The drug's mechanism is physiologically limited in bacteria that possess defense mechanisms, primarily those that produce beta-lactamase enzymes. These enzymes neutralize Cefaclor by chemically breaking its active beta-lactam ring, preventing the drug from reaching and inhibiting the PBPs. This enzymatic inactivation is the primary enzymatic constraint on the drug's action against resistant organisms.

Dosage and Administration Information

How to Use Sperex

The administration of Sperex (Cefaclor) follows instructions detailing the standardized route, dosage schedules, and specific conditions for intake.

Administration and Dosage Regimens

Sperex is for oral administration in all available forms, which include immediate-release capsules, tablets, and oral suspension, as well as extended-release (ER) tablets. The medicine is taken on a precise, divided schedule.

Usage Parameter Standard Adult Instructions (Immediate-Release)
Usual Dose Range 250 mg to 500 mg
Frequency Typically every 8 hours (three times daily)
Max Daily Dose 4,000 mg (4 g)
Duration Generally 7 to 10 days; minimum 10 days for streptococcal infections

Contextual Intake and Handling

Immediate-release Cefaclor can be taken with or without food, as total absorption is not affected. However, the extended-release (ER) tablets are typically taken with food, specifically within one hour of eating a meal. The oral suspension form requires reconstitution and must be shaken well before each measurement to ensure proper dosing.

For the ER tablet, a strict administration rule is that the tablet must be swallowed whole; it should not be crushed, split, or chewed, as this compromises the intended extended-release design. Dosage rules are modified for specific patient groups: pediatric dosing is based on body weight, and guidelines exist for patients undergoing hemodialysis.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sperex (Cefaclor)

Evidence for Use in Common Infections

Research on Sperex (Cefaclor) has explored its use in conditions such as those affecting the ears, throat, and respiratory system. The evidence base mainly consists of randomized controlled trials (RCTs) and comparative studies where Cefaclor was evaluated against other established antibacterial agents. These studies were designed to monitor two central measured outcomes: clinical response, which includes monitoring the evolution of infection symptoms, and bacteriological response, which includes monitoring the presence or absence of the specific pathogen.

Studies on Otitis Media (Middle Ear Infection)

Research explored the use of Cefaclor for patients presenting with acute middle ear infection, particularly in the population of pediatric patients. Researchers utilized short-term RCTs that measured clinical and microbiological responses. Studies reported measurements of how symptoms evolved during the short-term follow-up periods. Data for very young infants, specifically those under one month of age, remain insufficient, and the clinical data for this population have not been established.

Studies on Pharyngitis and Tonsillitis (Throat Infection)

For throat infections caused by Streptococcus pyogenes, research examined Cefaclor in adult and pediatric patients. Studies monitored outcomes related to physical discomfort and the rate of bacteriological response achieved. Studies examined how patient responses compared when Cefaclor was studied alongside other antibiotics, such as penicillin. A key limitation noted is the lack of substantial, long-term data specifically exploring the patterns of complications like acute rheumatic fever following the course of treatment.

Long-Term Evidence and Follow-up

The majority of clinical research conducted for Sperex focuses on the acute phase of infection. Study follow-up durations were limited, typically ranging from 7 to 14 days, with some extending to four weeks post-treatment. Long-term effects regarding the durability of response or managing chronic conditions are not fully established by the primary clinical trials. The existing evidence contributes to understanding symptom patterns only over defined, short time intervals.

What is Still Uncertain About Sperex: Research Gaps and Limitations

Research highlights that results apply only to infections caused by susceptible strains of bacteria. Research describes Cefaclor as inactive in laboratory settings against common resistant pathogens like Methicillin-Resistant S. aureus (MRSA). For certain indications, such as complicated urinary tract infections, systematic reviews indicate that findings were mixed or that study designs were inconsistent, making unified conclusions challenging. Research provides context but not individual predictions, and evidence highlights what is known — and what is still uncertain — about Sperex.

Key Studies & References

  1. Cefaclor for Oral Suspension, USP (NDA/ANDA/Labeling)
  2. Cefaclor revisited: A review of its characteristics and clinical use

Frequently Asked Questions (FAQ)

Common questions about Sperex (FAQ)


Q: Can I take Sperex if I am already using a vitamin supplement?

Regulatory documents and interaction checkers indicate that Cefaclor, the active ingredient in Sperex, has been studied for potential interactions with certain common vitamins and minerals like Vitamin C, D, K, and Zinc. Because of these findings, the combination of certain supplements and Sperex may be an element of a patient's treatment that is carefully monitored.


Q: Is Sperex known to interact with common pain relievers like ibuprofen?

Official interaction databases and prescribing information generally do not list a direct drug-to-drug interaction between Sperex (Cefaclor) and common, non-prescription pain relievers such as ibuprofen. Any changes to a person's medication regimen, including pain relievers, is a topic for discussion with a healthcare provider.


Q: Does Sperex interact with herbal teas or natural remedies?

While regulatory data does not list every single herbal tea or natural remedy, certain common supplements and botanicals, such as Ginkgo Biloba or Coenzyme Q10, have been checked for potential interactions. It is consistent with good practice that a person discuss all supplements, including herbal products, with their healthcare provider.


Q: Does the time of day matter when using Sperex?

The key instruction in the official product information is that Sperex must be taken on a precise, divided schedule, such as every 8 hours, to maintain consistent drug levels in the body. Therefore, maintaining a consistent, evenly spaced time for each dose throughout the day is the primary instruction.


Q: What is the difference between a side effect and an adverse reaction for Sperex?

Regulatory resources often use both terms to describe unwanted effects associated with the medicine. In general patient information, side effects may refer to the common, expected symptoms experienced during use, while adverse reactions encompass the full range of effects observed in clinical trials, categorized by how often they happen and their severity.


Q: Is Sperex used for other conditions besides the main one listed?

Yes, Sperex (Cefaclor) is indicated for treating a range of systemic bacterial infections beyond just the primary one. According to official prescribing information, this includes otitis media (middle ear infection), infections of the respiratory tract, skin and skin structure infections, and specific urinary tract infections when caused by susceptible bacteria.


Q: Is it normal to feel a change within the first few days of starting Sperex?

Patient counseling information often notes that it is common to feel better early in the course of therapy as the infection begins to clear. However, official advice states that the full course of the medication should be completed as prescribed to fully resolve the infection.


Q: Is Sperex considered a long-term treatment option?

Sperex is generally prescribed as a short-term treatment to resolve acute bacterial infections, typically for 7 to 10 days. The majority of clinical research focuses on the acute phase of infection, and long-term data regarding its use for chronic conditions are not established by the primary clinical trial evidence.


Q: Are there any specific lifestyle changes mentioned in the product information that affect Sperex?

Official guidance includes the necessity of using the medicine only to treat proven or strongly suspected bacterial infections, a component of antibiotic stewardship. Additionally, official labels include a technical safety point regarding the potential for false-positive urine glucose test results with certain testing methods for diabetic patients.


Q: What are the most commonly reported reasons for stopping Sperex?

Official documents note that severe events such as documented allergic reactions and serious conditions like Pseudomembranous colitis are the primary reasons for drug discontinuation. While other issues, such as diarrhea, are common, they are usually not severe enough to require stopping treatment.


Q: If I miss a dose of Sperex, does that affect how it works overall?

Product information advises that a missed dose should be taken as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped. Product information describes that double doses should be avoided to prevent an increased risk of unwanted effects.


Q: How long does it typically take for Sperex to build up in the body?

Pharmacological data from studies indicate that the maximum concentration of Sperex in the bloodstream is typically reached within 30 to 60 minutes after taking the medicine. This is a measure of how quickly the drug is absorbed into the body.


Q: Can older adults use Sperex without any special precautions being mentioned?

Official guidance notes that dosage changes are typically not required for elderly patients who have normal kidney function. However, the elderly, particularly those with severely impaired kidney function, are listed as being at risk for potential neurological adverse reactions.


Q: If I have kidney problems, does that automatically mean I can't use Sperex?

No. Markedly impaired renal function (severe kidney problems) is listed as a condition requiring caution and careful observation during administration, not an absolute contraindication. Regulatory documents indicate that dosage adjustments are typically not necessary for moderate to severe impairment, but patients must be closely observed.


Q: Why do official documents mention genetic factors related to Sperex response?

Clinical research underlying official safety profiles has explored genetic factors, such as specific inherited HLA types and other gene variants, in relation to the risk of severe hypersensitivity reactions (anaphylaxis) to Sperex in certain patient populations. This information contributes to understanding the drug's safety profile.


Q: What are the possible symptoms of a significant interaction with Sperex?

Symptoms related to a significant interaction may include increased bleeding or bruising when taken with anticoagulants like Warfarin. Neurological symptoms such as encephalopathy, seizures, or tremors are also listed as a risk, particularly in patients with impaired kidney function.


Q: How is the long-term benefit of Sperex described in the clinical research?

Clinical research focuses mainly on short-term clinical and bacteriological responses during the acute treatment phase (typically 7 to 14 days). Long-term effects, such as the effectiveness in preventing subsequent chronic conditions, are not fully established by the primary clinical trial data.


Q: Can a minor side effect of Sperex become more serious over time?

Official safety warnings describe the potential for serious adverse reactions to emerge. This includes the risk of developing Pseudomembranous colitis, a serious adverse reaction that can arise during or even after treatment is completed, or the potential for a less severe reaction to escalate into a serious allergic reaction.


Q: Can I use Sperex if I have a known allergy to other similar medicines?

Official warnings primarily focus on the documented risk of cross-sensitivity with antibiotics in the same class, specifically the penicillin group. Disclosure and review of a person's complete allergy history with a healthcare provider is consistent with safe usage practices.


Q: Is Sperex a controlled substance?

No. Cefaclor (Sperex) is generally not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or equivalent international agencies. It is an antibiotic intended only for prescription use.


Q: Do health authorities recommend a follow-up schedule when starting Sperex?

Regulatory dosage information defines the duration of therapy as continuing for a specified period (e.g., 48 to 72 hours) after the patient becomes asymptomatic or until evidence of bacterial eradication is obtained. This is generally how treatment completion is described.


Q: Why are certain populations excluded from the main Sperex clinical trials?

Regulatory documents state that for specific populations, such as infants under one month old and children under 16 years for the extended-release tablet, safety and efficacy have not been established in clinical trials. This lack of established data leads to restrictions or cautions for using the drug in those specific groups.


Q: Does Sperex affect fertility according to regulatory documents?

Official documents note that while adequate studies in humans have not been performed to fully assess fertility effects, studies conducted with cefaclor in animals did not show evidence of impaired fertility.


Q: Are there any blood tests that are recommended or required when using Sperex?

While routine blood tests are generally not required, official labels recommend considering regular monitoring of prothrombin time for patients using Sperex alongside anticoagulants (blood thinners) like Warfarin. Additionally, Sperex may cause a false-positive result on certain laboratory tests.


Q: What does official guidance say about using Sperex if I have diabetes?

Official guidance for diabetic patients notes a technical safety point: Sperex may cause a false-positive reaction for glucose in the urine when tested using non-specific methods (such as Benedict's or Fehling's solutions). Testing methods for glucose should be discussed with a healthcare provider.


Q: How are potential long-term risks described in the official safety summaries for Sperex?

Safety summaries note that prolonged use of Sperex carries a risk of superinfection due to the overgrowth of non-susceptible organisms. There is also a potential concern regarding the development of antibiotic resistance when the drug is used for extended periods.


Q: Does Sperex have any known effects on alertness or driving ability?

Official documents list side effects that may affect alertness, such as dizziness and drowsiness, though their frequency is not always known. It is generally advised to be cautious when performing activities like driving or operating machinery if these effects are experienced.


Q: Are there special warnings for people with liver disease when using Sperex?

Official safety information indicates that patients with pre-existing liver damage may have an increased risk of certain side effects. Rare but serious adverse reactions, including transient hepatitis and cholestatic jaundice, are also noted in the product profile.

How should Sperex be stored and disposed of?

Storage

Sperex should be stored at room temperature, away from direct heat, moisture, and light. It is critical to keep this medication, and all others, out of the reach of children and pets to prevent accidental ingestion. Never store Sperex in the bathroom, as high humidity can degrade the medicine's effectiveness. Always ensure the container is tightly closed.

Disposal

The most recommended method for the disposal of unused or expired Sperex is to utilize a drug take-back program. Many pharmacies, hospitals, and police departments offer drop-off boxes. If a take-back option is unavailable, the medication can typically be thrown in the household trash. To prepare for trash disposal, mix the tablets with an unappealing substance, such as dirt, cat litter, or used coffee grounds, and place this mixture in a sealed plastic bag or container. Do not crush the tablets. Remove or conceal all personal identifying information on the prescription label before disposing of the empty packaging. Do not flush Sperex down the toilet or pour it down a sink unless specifically instructed by the medication guide or a healthcare provider.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sperex found in:

A-Z Index: